G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 113.65 INR 3.8% Market Closed
Market Cap: 299.1B INR
Have any thoughts about
Global Health Ltd?
Write Note

Global Health Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Global Health Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
G
Global Health Ltd
NSE:MEDANTA
Other Current Assets
â‚ą132.5m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Krishna Institute of Medical Sciences Ltd
NSE:KIMS
Other Current Assets
â‚ą125m
CAGR 3-Years
6%
CAGR 5-Years
68%
CAGR 10-Years
N/A
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
Other Current Assets
â‚ą4.7B
CAGR 3-Years
18%
CAGR 5-Years
34%
CAGR 10-Years
N/A
F
Fortis Healthcare Ltd
NSE:FORTIS
Other Current Assets
â‚ą400.8m
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Max Healthcare Institute Ltd
NSE:MAXHEALTH
Other Current Assets
â‚ą1B
CAGR 3-Years
41%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Narayana Hrudayalaya Ltd
NSE:NH
Other Current Assets
â‚ą645.4m
CAGR 3-Years
-2%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Global Health Ltd
Glance View

Market Cap
299B INR
Industry
Health Care

Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, air ambulance, patient support services, and others.

MEDANTA Intrinsic Value
792.23 INR
Overvaluation 29%
Intrinsic Value
Price
G

See Also

What is Global Health Ltd's Other Current Assets?
Other Current Assets
132.5m INR

Based on the financial report for Mar 31, 2024, Global Health Ltd's Other Current Assets amounts to 132.5m INR.

What is Global Health Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 3Y
28%

Over the last year, the Other Current Assets growth was 0%. The average annual Other Current Assets growth rates for Global Health Ltd have been 28% over the past three years .

Back to Top